ACU vs PM

ACU presents a dichotomy between a rock-solid balance sheet and deteriorating short-term operational momentum. The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the absence of an Altman Z-Score is offset by an exceptionally low Debt/Equity ratio (0.24) and a high Current Ratio (4.21). While the stock is fairly valued—trading between its Graham Number ($40.16) and Intrinsic Value ($48.95)—the recent Q/Q EPS collapse of -47.8% and a bearish technical trend (0/100) suggest significant near-term headwinds.

Philip Morris International (PM) presents a compelling investment case supported by strong profitability, consistent earnings growth, and a resilient dividend profile. Despite near-term price weakness over the past six months (-7.3%), the stock has delivered exceptional long-term returns (+153.1% over 5Y), underpinned by robust YoY EPS growth of 17.3% and a track record of beating earnings estimates in 22 of the last 25 quarters. The company’s high operating margin (40.75%) and gross margin (66.92%) reflect pricing power and cost discipline in a defensive sector, while its forward P/E of 21.59 appears justified given growth and stability. Analysts concur with a unanimous buy rating and a $185.75 target price, implying ~19.5% upside, reinforcing confidence in continued outperformance.